December 10, 2013 | By DEEPTI RAMESH
PCI Synthesis: Increased regulatory scrutiny, wage inflation in India and China, to impact industry in 2014 PCI Synthesis (Newburyport, MA), a manufacturer of new chemical entities (NCE), generic active pharmaceutical ingredients (APIs), complex pharmaceutical intermediates, and other specialty chemical products, has announced a list of trends that are likely to impact the generic drug and emerging biotech...
December 6, 2013 | By LINDSAY FROST
This Week in CW: Dow Chemical announced this week that it is carving out a chunk of its chlorine value chain representing $5 billion in annual revenue for disposal as part of the company’s long-term shift to higher-margin, noncyclical activities. Over 40 manufacturing facilities at 11 sites and nearly 2,000 employees are affected. The assets are to be split into three units: epoxy, chlorinated...
December 3, 2013 | By DEEPTI RAMESH
Merck KGaA eyes pharma acquisitions in the US Merck KGaA (Darmstadt, Germany) is looking to strengthen its presence in the prescription pharmaceuticals market in the United States and is open to more collaborations and acquisitions. At a press briefing last month in Yavne, Israel, the location of Merck Serono’s subsidiary in Israel, Stefan Oschmann, board member Merck KGaA/pharma and consumer health...
November 26, 2013 | By DEEPTI RAMESH
Johnson Matthey’s fine chemicals division reports rise in sales The fine chemicals division of Johnson Matthey (London), which comprises the company's active pharmaceutical ingredient (API) manufacturing business, the catalysis and chiral technologies business, and research chemicals, generated revenue of £185 million ($298 million), in its fiscal first half ended 30 September 2013, up 8%...
November 22, 2013 | By LINDSAY FROST
This Week in CW: The Gulf Petrochemical and Chemical Association’s (GCPA; Dubai) annual forum kicked off this week in Dubai, with industry coming together to address global issues. On Wednesday, the first day of the forum, the key topics included innovation and shortage of feedstocks in the GCC states. Mohamed Al Mady, chairman of GPCA and CEO of Sabic in his opening address said that the GCC states...
November 19, 2013 | By DEEPTI RAMESH
DSM and JLL form $2-billion pharma services firm by merging DSM Pharmaceutical Products with Patheon DSM and JLL Partners (New York), a middle-market private equity firm, will create a new company, which will be a leading global contract development and manufacturing organization (CDMO) for the pharmaceutical industry, with anticipated sales of about $2 billion in 2014, DSM says. The company will be formed...
November 15, 2013 | By LINDSAY FROST
This Week in CW: A few more companies reported earnings this week as the season comes to an end. K+S’ third-quarter revenues were down 11%, to €817.7 million, with potash and magnesium products declining 18.5%, to €456.7 million. Merck KGaA reported a much improved third-quarter net income and organic sales in a challenging market environment and raised its Ebitda guidance for the...
November 14, 2013 | By BOB HARRELL, CEO OF MANAGEMENT CONTROLS
Project cost engineers overseeing maintenance shutdowns have built some amazing Excel spreadsheets used to calculate hours and costs and create forecasts. But, spreadsheets are only as accurate as the shift-by-shift direct field hours reported by each vendor plus cost reports pulled from an enterprise resource planning tool. When headcount peaks at 1,500/day ($1 million/day), project execution teams need...
November 12, 2013 | By DEEPTI RAMESH
CPhI 2013: Bullish mood at Frankfurt CPhI, the largest annual trade fair for the global pharmaceutical and pharma ingredients industry and held recently at Frankfurt, attracted about 2,200 exhibitors and 34,000 visitors during its three days’ time. The mood of companies interviewed by CW was positive. “Pharmaceuticals have come through the worst of the trough, and the generic cliff we saw a few...
November 8, 2013 | By LINDSAY FROST
This Week in CW: Earnings season is slowing down as fewer companies reported this week. In Europe, Arkema posted Ebitda of €233 million ($315 million) in third-quarter 2013, a decline of 12.4% year-on-year (YoY). Ebitda margin for the period was 15.6% compared with 16.6% in the year-ago period. Borealis’ net profit for the third quarter rose 2% to €131 million ($175.9 million) on sales 6%...
ABOUT CHEM IDEAS
Welcome to Chem Ideas, the place for opinions and perspective on the key issues affecting the global chemicals industry. This zone features articles by Chemweek’s regular editors as well as a team of established experts with insights across the chemicals industry. If you would like to contribute a blog or opinion piece contact Lindsay.Frost@ihs.com.
CLICK HERE TO LEARN ABOUT CHEMWEEK'S EDITORS
ABOUT OUR GUEST AUTHORS
Fine Chemicals / Pharma
Girish Malhotra is the president and founder of Epcot International, an international consulting firm covering chemical manufacture. Girish is an established industry figure having held senior positions at companies including ExxonMobil and Sherwin Williams. He can be reached at firstname.lastname@example.org
Lawrence D. Sloan became Socma's
President in early 2010. He says he will continue to drive up the interests of his members on issues including regulation and best business practice.
Lisa Allen is the Technical Manager of ReachReady, the Reach services body affiliated to the Chemical Industries Assocation (CIA; U.K.).
She spends much of her time addressing concerns raised by ReachReady’s customers about Reach.
Kathryn Sheridan is the founder of Sustainability Consult, providing public relations support with a sustainability focus to a number of chemical industry clients, as well as to other sectors. Sustainability Consult helps organisations develop, promote and communicate their sustainability strategies, plans and activities. email@example.com
Rubber and Plastics
Lou Reade is a freelance journalist and expert in the rubber and plastics fields. Based in the U.K. Lou has more than a decade writing in about rubber and plastics manufacture with a wealth of experience gained while writing for the leading publications in the field in the U.K. and wider afield. Loureade@talk21.com.
Giles Chappell is an attorney based in Geneva. His practice focuses on chemicals—specifically REACH and the CLP Regulation, product safety legislation, environmental and trade compliance, and market access issues. He was recommended in 2012 by the Chambers & Partners legal directory. firstname.lastname@example.org
Steve Roberts is an attorney who practices in the rapidly developing area of homeland security law and regulation. Steve writes and speaks frequently on the legal aspects of homeland security and counterterrorism affecting the nation’s critical infrastructure. www.chemicalsecurity.com